Literature DB >> 10150212

Compliance of an apatitic calcium phosphate cement with the short-term clinical requirements in bone surgery, orthopaedics and dentistry.

M P Ginebra1, E Fernández, M G Boltong, O Bermúdez, J A Planell, F C Driessens.   

Abstract

An apatitic calcium phosphate cement was developed containing a nucleator in its powder and an accelerator in the liquid and having an initial setting time of 7.5 min and a final setting time of 12.5 min according to testing with Gillmore needles at room temperature. At body temperature the initial setting time is 6 min, after which the wound can be closed. The dough time (during which it can be deformed without damaging its microstructure) is 4 min. Therefore, the time lost during an operation with this material is 2 min. The product does not shrink or expand during setting, neither is there a thermal effect; it does not swell or disintegrate upon exposure to aqueous fluids after initial setting. Upon soaking in Ringer's solution the product obtains a final compressive strength of 40 MPa and 65% of that strength is reached within 6 h at body temperature. Cytotoxicity is absent. Applications are envisaged in bone surgery, orthopaedics and dentistry, a.o. for acceleration of the osseointegration of metal endoprostheses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10150212     DOI: 10.1016/0267-6605(94)90018-3

Source DB:  PubMed          Journal:  Clin Mater        ISSN: 0267-6605


  16 in total

1.  Some factors controlling the injectability of calcium phosphate bone cements.

Authors:  I Khairoun; M G Boltong; F C Driessens; J A Planell
Journal:  J Mater Sci Mater Med       Date:  1998-08       Impact factor: 3.896

2.  Production and characterization of new calcium phosphate bone cements in the CaHPO4-alpha-Ca3(PO4)2 system: pH, workability and setting times.

Authors:  E Fernández; F J Gil; M P Ginebra; F C Driessens; J A Planell; S M Best
Journal:  J Mater Sci Mater Med       Date:  1999-04       Impact factor: 3.896

3.  Biodegradable β-tricalcium phosphate cement with anti-washout property based on chelate-setting mechanism of inositol phosphate.

Authors:  Toshiisa Konishi; Shuhei Takahashi; Zhi Zhuang; Kohei Nagata; Minori Mizumoto; Michiyo Honda; Yasuhiro Takeuchi; Hitomi Matsunari; Hiroshi Nagashima; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2013-03-08       Impact factor: 3.896

4.  Optimisation of the mechanical and handling properties of an injectable calcium phosphate cement.

Authors:  R M O'Hara; N J Dunne; J F Orr; F J Buchanan; R K Wilcox; D C Barton
Journal:  J Mater Sci Mater Med       Date:  2010-01-22       Impact factor: 3.896

5.  Limited compliance of some apatitic calcium phosphate bone cements with clinical requirements.

Authors:  I Khairoun; M G Boltong; F C Driessens; J A Planell
Journal:  J Mater Sci Mater Med       Date:  1998-11       Impact factor: 3.896

6.  Incorporation of a controlled-release glass into a calcium phosphate cement.

Authors:  I Khairoun; M G Boltong; F J Gil; F C Driessens; J A Planell; M M Seijas; S Martínez
Journal:  J Mater Sci Mater Med       Date:  1999-04       Impact factor: 3.896

7.  Calcium phosphate bone cements for clinical applications. Part II: precipitate formation during setting reactions.

Authors:  E Fernández; F J Gil; M P Ginebra; F C Driessens; J A Planell; S M Best
Journal:  J Mater Sci Mater Med       Date:  1999-03       Impact factor: 3.896

8.  pH-metric study of the setting reaction of monocalcium phosphate monohydrate/calcium oxide-based cements.

Authors:  Josiane Nurit; Jacques Margerit; Alain Terol; Philippe Boudeville
Journal:  J Mater Sci Mater Med       Date:  2002-11       Impact factor: 3.896

9.  Effect of temperature and immersion on the setting of some calcium phosphate cements.

Authors:  F C Driessens; M G Boltong; E A De Maeyer; R M Verbeeck; R Wenz
Journal:  J Mater Sci Mater Med       Date:  2000-07       Impact factor: 3.896

10.  Monitoring the setting of calcium-based bone cements using pulse-echo ultrasound.

Authors:  M Nilsson; J Carlson; E Fernandez; J A Planell
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.